First Manhattan’s Sophiris Bio, Inc. SPHS Stock Holding History

First Manhattan’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-353,686	Closed	-$1.04M	–	1608
2014 Q3	$1.04M	Sell	353,686 -251,456	-42%	-$708K	0.01%	416
2014 Q2	$1.35M	Sell	605,142 -146,700	-20%	-$434K	0.01%	377
2014 Q1	$2.5M	Sell	751,842 -248,658	-25%	-$974K	0.02%	315
2013 Q4	$3.7M	Hold	1,000,500	–	–	0.02%	267
2013 Q3	$4.68M	Buy	+1,000,500	New	+$4.61M	0.03%	233

Other funds holding SPHS

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

First Manhattan's SPHS Position: Q4 2014 in Review

First Manhattan sold out of Sophiris Bio, Inc. (SPHS) in Q4 2014, closing a stake of 353,686 shares — an estimated $1.04M sold.

First Manhattan first reported a position in SPHS in Q3 2013 and held it in 5 quarters. The position peaked at $4.68M in Q3 2013. 14 funds tracked by Wall St. Rank hold SPHS as of Q4 2014.

First Manhattan reported no remaining Sophiris Bio, Inc. position as of Q4 2014 after selling out during the quarter.
First Manhattan sold 353,686 Sophiris Bio, Inc. shares in Q4 2014, an estimated $1.04M.
First Manhattan first reported a position in Sophiris Bio, Inc. in Q3 2013 and held it in 5 quarters.
First Manhattan's Sophiris Bio, Inc. position peaked at $4.68M in Q3 2013.
14 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q4 2014.

Based on First Manhattan's 13F filing for Q4 2014, filed 20 Jan 2015.